<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/656399BA-FD31-4363-8414-4E77C723C46C"><gtr:id>656399BA-FD31-4363-8414-4E77C723C46C</gtr:id><gtr:name>Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5F600791-9929-4BAE-9186-DB9F207BD7C1"><gtr:id>5F600791-9929-4BAE-9186-DB9F207BD7C1</gtr:id><gtr:name>McGill University</gtr:name><gtr:address><gtr:line1>845 Sherbrooke Street W</gtr:line1><gtr:line4>Montreal</gtr:line4><gtr:line5>Quebec, H3A 2T5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F649AB83-DC92-4360-807F-BBFEF0DE8EE4"><gtr:id>F649AB83-DC92-4360-807F-BBFEF0DE8EE4</gtr:id><gtr:name>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AFCF678A-5FC2-4D86-B376-12C1457C0F14"><gtr:id>AFCF678A-5FC2-4D86-B376-12C1457C0F14</gtr:id><gtr:name>Columbia University Medical Center</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/656399BA-FD31-4363-8414-4E77C723C46C"><gtr:id>656399BA-FD31-4363-8414-4E77C723C46C</gtr:id><gtr:name>Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AF1D7ABA-67D6-4979-8C08-7C0F7DE524CF"><gtr:id>AF1D7ABA-67D6-4979-8C08-7C0F7DE524CF</gtr:id><gtr:firstName>Shamima</gtr:firstName><gtr:surname>Rahman</gtr:surname><gtr:orcidId>0000-0003-2088-730X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B9488D32-EC8E-41AA-9D13-9600C3C7ED0D"><gtr:id>B9488D32-EC8E-41AA-9D13-9600C3C7ED0D</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Heales</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8F3A3053-8676-482B-89EF-9C7F0E041D52"><gtr:id>8F3A3053-8676-482B-89EF-9C7F0E041D52</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Vivian</gtr:otherNames><gtr:surname>Leonard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/002FC006-2518-458A-AB1F-FF4586FFE8D7"><gtr:id>002FC006-2518-458A-AB1F-FF4586FFE8D7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Hanna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0200335"><gtr:id>55723C3B-815C-4BB0-A2DE-5F587DAA2C81</gtr:id><gtr:title>Nuclear Genes for Mitochondrial Respiratory Chain Disorders in Childhood</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0200335</gtr:grantReference><gtr:abstractText>Mitochondria are small structures present in virtually all human cells. They are the ?powerstations? of the cell since they are responsible for generating most of the cellular ?energy? in the form of adenosine triphosphate (ATP). This is done in a series of enzymatic reactions known as the respiratory chain and oxidative phosphorylation system. Defects of the human mitochondrial respiratory chain are responsible for a significant burden of disease, particularly in childhood. The clinical signs of these disorders are extremely varied since they can affect any organ system of the body, particularly the brain, muscle, heart, kidney, liver and gut. In very few children with mitochondrial disease can the genetic cause for their disease be identified.

Studies in yeast have indicated that more than 100 genes are involved in the manufacture and assembly of a functional mitochondrial respiratory chain. Defects in the human equivalents of all these yeast genes, together with defects in other as yet undiscovered genes, may be responsible for mitochondrial respiratory chain disease in childhood.

Because of this complexity traditional techniques cannot be used to map and isolate the genes responsible for human mitochondrial respiratory chain disease. New strategies need to be employed to identify these genes. We propose to use a technique known as microcell-mediated chromosome transfer. In this technique individual chromosomes from healthy donor cells (with normal mitochondrial respiratory chain function) are tagged and then transferred, by cell fusion, to patient cell lines with deficient activity of cytochrome oxidase (COX), one component of the mitochondrial respiratory chain. The fused cells are called hybrids and these hybrids are analysed to see if they still have COX deficiency. Hybrids with COX activity that has been restored must have received a normal copy of the gene responsible for the COX deficiency during the chromosome transfer process. It can be inferred that the chromosome that has been transferred contains this gene, and more detailed genetic mapping techniques will then be used to identify this gene.

Identification of new disease-causing genes is the first step in improving our understanding of mitochondrial disease in childhood. The next step is to find out how these genes work, and in so doing we hope to discover new treatments for children with mitochondrial respiratory chain disorders.</gtr:abstractText><gtr:technicalSummary>The mitochondrial respiratory chain and oxidative phosphorylation system (complexes I-V) produce ATP by aerobic metabolism. Thirteen of the 80 polypeptide subunits of the respiratory chain/oxidative phosphorylation system are encoded on the mitochondrial genome. The remaining subunits are nuclear-encoded. Clinical presentations of mitochondrial respiratory chain disease in childhood are extremely heterogeneous. Most patients do not have a molecular genetic diagnosis, and mutations in the respiratory chain polypeptide subunits appear to be rare. It is likely that most childhood-onset mitochondrial respiratory chain disease is caused by nuclear regulatory genes that have not yet been characterised in humans. We aim to identify these recessive genes by a somatic cell genetic strategy involving microcell-mediated chromosome transfer. The ability to assay the activity of one component of the respiratory chain, cytochrome oxidase (COX), in cell cultures means that somatic cell fusion and microcell-mediated chromosome transfer studies are a logical way to investigate the genetic origin of COX deficiency in patient cell lines. This has previously been used successfully to demonstrate that mutations in the SURF1 gene are responsible for a large proportion of cases of Leigh syndrome with COX deficiency. Previous studies using somatic cell fusion have identified a likely nuclear genetic origin for COX deficiency in a number of patients seen in our hospital. So far these patients can be divided into 5 complementation groups. We will now use a microcell fusion method to transfer individual chromosomes into patient cell lines, to determine which chromosome restores COX deficiency in these cell lines. A panel of human:mouse monochromosomal hybrid cell lines containing human chromosomes tagged with a selectable marker (HyTK) will be used as the source of donor human chromosomes. All 22 autosomes and the X chromosome are sequentially transferred into the recipient patient cell line by microcell-mediated chromosome transfer. The chromosome whose transfer restores COX activity to the patient cells can be inferred to contain the gene of interest. Fine mapping techniques will then be used to isolate the responsible gene.</gtr:technicalSummary><gtr:fund><gtr:end>2008-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>191512</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>yeast Coq9</gtr:description><gtr:id>FED92D35-1CF8-419C-B695-47D264342916</gtr:id><gtr:impact>joint publication just submitted</gtr:impact><gtr:outcomeId>5461fe864c0e51.65474726-1</gtr:outcomeId><gtr:partnerContribution>yeast studies to investigate function of the yeast Coq9 protein</gtr:partnerContribution><gtr:piContribution>provided plasmid containing human COQ9 gene and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>maestro</gtr:description><gtr:id>A353A86A-CA84-46D2-B540-B6BD653C73AF</gtr:id><gtr:impact>Helped to narrow list of candidate genes in critical region in homozygosity mapping project, and to identify a mutation in a putative complex I assembly gene in a family we were investigating. 
Resulted in joint publication:
Fassone et al 2010 Human Molecular Genetics</gtr:impact><gtr:outcomeId>46737A0167D-1</gtr:outcomeId><gtr:partnerContribution>The Harvard group provided up to date information about the mitochondrial proteome, which has helped my group to narrow the number of candidate genes in homozygosity mapping studies aiming to identify nuclear genes that cause mitochondrial disease.</gtr:partnerContribution><gtr:piContribution>Harvard University - Provided up to date information about the mitochondrial proteome My group used this data to narrow the number of candidate genes in homozygosity mapping studies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>surf1</gtr:description><gtr:id>96995D68-53F6-4767-AFA5-2B26DFEFC777</gtr:id><gtr:impact>Joint publication:
Wedatilake et al 2013 Orphanet J Rare Dis</gtr:impact><gtr:outcomeId>Q3uhx9n8mpW-1</gtr:outcomeId><gtr:partnerContribution>Identification of patients in other centres and provision of molecular data</gtr:partnerContribution><gtr:piContribution>Natural history study (diagnosis of 20 local cases and collection and analysis of national clinical, biochemical and radiological data from &amp;gt;10 centres; wrote manuscript)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>polg</gtr:description><gtr:id>84A3B4E4-708F-4339-92AE-D2CB98548CB8</gtr:id><gtr:impact>Two publications in high impact factor journals in 2009: 

Taanman et al 2009 Human Mutation 
Wolf et al 2009 Epilepsia</gtr:impact><gtr:outcomeId>2C6DFA305A9-1</gtr:outcomeId><gtr:partnerContribution>Two research publications in high impact factor journals.</gtr:partnerContribution><gtr:piContribution>The group at the University Department of Clinical Neurosciences of the Royal Free and UCL Medical School has performed functional studies of the DNA polymerase gamma in cell lines from patients in whom my group has identified mutations in the POLG gene, which encodes the catalytic subunit of this enzyme.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mitochondrial Disease Sequence Data Resource (MSeqDR) Consortium</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>MSeqDR</gtr:description><gtr:id>456A4055-83C2-43ED-A944-9E1734DA2F97</gtr:id><gtr:impact>Mitochondrial database and sequence resource</gtr:impact><gtr:outcomeId>54573190f2cf42.90487282-1</gtr:outcomeId><gtr:partnerContribution>MSeqDR Consortium is a grass root effort supported by United Mitochondrial Disease Foundation (UMDF) and extramural program officers at NICHD, NIH.
MSeqDR Consortium was initiated at the June 2012 Annual Meeting of the United Mitochondrial Disease Foundation (UMDF).
 This effort has engaged and united more than 100 mitochondrial disease experts.
 MSeqDR major components are: Data Capture, Gbrowse, MSeqDR-LSDB, and Account &amp;amp; Access Management.</gtr:partnerContribution><gtr:piContribution>Mitochondrial expertise, including mitochondrial DNA and whole exome sequencing knowledge</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University Medical Center</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>coenzyme Q10</gtr:description><gtr:id>5E3229E5-6298-4AAF-9A16-1DF8D5BCF30A</gtr:id><gtr:impact>Invited to lead European Neuromuscular Consortium (ENMC) workshop: Diagnosis and treatment of coenzyme Q10 deficiency

Joint publications: 
Duncan et al 2009 American Journal of Human Genetics
Quinzii et al 2010 FASEB Journal
Lopez et al 2010 PLoS One
Rahman et al 2011 Neuromuscular Disorders (ENMC workshop report)</gtr:impact><gtr:outcomeId>18CFD113C1A-1</gtr:outcomeId><gtr:partnerContribution>The Columbia NY group investigated coenzyme Q10 biosynthesis in fibroblasts of interest provided by our group. This data was essential to our publication about the COQ9 gene in Am J Hum Genet 2009</gtr:partnerContribution><gtr:piContribution>The Columbia group in New York studied coenzyme Q10 biosynthesis in fibroblasts from a patient in whom we had identified a novel gene, COQ9, as the cause of his mitochondrial dysfunction, using homozygosity mapping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>McGill University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Montreal Neurological Institute and Hospital</gtr:department><gtr:description>sco1</gtr:description><gtr:id>7776EE23-A741-480D-998B-F44B53091C62</gtr:id><gtr:impact>Joint publication:
Leary et al 2013 Human Mutat</gtr:impact><gtr:outcomeId>tYHUbSjf5wS-1</gtr:outcomeId><gtr:partnerContribution>Functional studies of mitochondrial biological processes</gtr:partnerContribution><gtr:piContribution>Provided patient material and clinical information</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Cell and Developmental Biology</gtr:department><gtr:description>cisplatin</gtr:description><gtr:id>C7A1E997-F1C6-4BD1-8404-F6B55375ECB3</gtr:id><gtr:impact>Identified a cellular mechanism of cisplatin resistance.
Joint publication: Yao et al 2012 Oncogene
Joint grant applications to CRUK and MRC</gtr:impact><gtr:outcomeId>TqCAR79R6H9-1</gtr:outcomeId><gtr:partnerContribution>functional studies to investigate mitochondrial biogenesis in cisplatin-resistant lung carcinoma cell lines</gtr:partnerContribution><gtr:piContribution>interpretation of cybrid data; high-throughput sequencing of mitochondrial DNA from cisplatin-resistant lung carcinoma cell lines; design and interpretation of functional studies to investigate putative cellular mechanisms of cisplatin resistance</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>modelling</gtr:description><gtr:id>A9FF6516-53E6-483E-B77C-D027DDD6120B</gtr:id><gtr:impact>Joint publications:
Duncan et al 2009 Am J Hum Genet
Fassone et al 2010 Hum Mol Genet
Pitceathly et al 2011 J Med Genet
Pitceathly et al 2013 JAMA Neurol</gtr:impact><gtr:outcomeId>qk5rFUWviVK-1</gtr:outcomeId><gtr:partnerContribution>Partner at NIMR generates structural models of the putative disease-causing proteins and models the structural/functional effects of the mutations identified by my team.</gtr:partnerContribution><gtr:piContribution>Identified mutations in nuclear-encoded mitochondrial proteins responsible for human mitochondrial disease.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Center for Scientific Research (Centre National de la Recherche Scientifique CNRS)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Center for Molecular Genetics (CGM)</gtr:department><gtr:description>yeast studies</gtr:description><gtr:id>608836B5-2395-4FD3-A0F4-DA874FA7B72A</gtr:id><gtr:impact>Joint publications:
Duncan et al 2009 American Journal of Human Genetics</gtr:impact><gtr:outcomeId>696FA9D5E9D-1</gtr:outcomeId><gtr:partnerContribution>The CNRS group studied mutations that we have identified in putative mitochondrial proteins and demonstrated whether these mutations affected respiratory function in yeast model systems. This data was essential to our publication about the novel COQ9 gene involved in coenzyme Q10 biosynthesis in Am J Hum Genet 2009.</gtr:partnerContribution><gtr:piContribution>The CNRS group studies mutations (identified by us in human patients) in yeast model systems to determine whether these mutations affect yeast respiratory function.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute of Neurological Disorders and Stroke (NINDS)</gtr:department><gtr:description>NINDS common data elements</gtr:description><gtr:id>EF00823C-16FC-40A6-AEA4-81D5F50D5C54</gtr:id><gtr:impact>The first set of Common Data Elements (CDEs) for Mitochondrial Disease will be available in January 2015.</gtr:impact><gtr:outcomeId>54573314a4d345.93097057-1</gtr:outcomeId><gtr:partnerContribution>The National Institute of Neurological Disorders and Stroke (NINDS) and other Federal agencies and international organizations have the common mission of developing data standards for clinical research. Currently, the subject-specific working groups are developing these data elements.</gtr:partnerContribution><gtr:piContribution>Mitochondrial disease clinical expertise</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Vademecum Metabolicum</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>78142268-C16D-4C11-8440-6C4A3D6DD650</gtr:id><gtr:impact>Handbook of metabolic medicine for doctors, nurses, biochemists and dietitians involved in the care of patients with metabolic diseases.

Freely available book disseminated by Nutricia</gtr:impact><gtr:outcomeId>j7mVy3P5oSj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.milupa-metabolics.com/experten.php?sourceId=181&amp;sysId=215</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'International Mito Patients' meeting, Muscular Dystrophy Campaign, London</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A0290405-FD36-4D35-9707-F6B4A26B5186</gtr:id><gtr:impact>Patient representatives of patient support groups from 10 European countries met at the Muscular Dystrophy Campaign headquarters in London in January 2010 to brainstorm a new initiative to improve the treatments available to patients affected by mitochondrial diseases.

The patient representatives resolved to:
1. Take this initiative forward
2. Set up an international patient registry</gtr:impact><gtr:outcomeId>UjeW18GP28k</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.mitopatients.org</gtr:url><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICH Practical neurology study days</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>52735AC0-631C-43D0-A7C5-61E74510E621</gtr:id><gtr:impact>Lecture about diagnosis and management of mitochondrial diseases, including reference to my research into the identification of nuclear genes for mitochondrial diseases.

Positive feedback from participants (high scores on evaluation forms); increased referral of patients to my clinics and my research project.</gtr:impact><gtr:outcomeId>269A4E70FFB</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=4&amp;ved=0CDIQFjAD&amp;url=http%3A%2F%2Fwww.csp.org.uk%2Fsites%2Ffiles%2Fcsp%2Fneurology_flyer_standard_at_19_11_13.pdf&amp;ei=ddhSVK-eJZfsaKvKgvAF&amp;usg=AFQjCNHyL7uvWBs8XBkhORHYRIrfZX7bAw&amp;bvm=bv.78677474,</gtr:url><gtr:year>Pre-2006,2006,2007,2009,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Trent Metabolic study day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1AAB7E7F-A99B-414C-9B66-51690CB94740</gtr:id><gtr:impact>Lectured on mitochondrial epilepsy to doctors, biochemists, nurses and dietitians interested in metabolic medicine - included our research findings in this talk

Patients referred for further research studies</gtr:impact><gtr:outcomeId>Z9C59CJmB5p</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Biological Sciences BSc</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>245741F3-606B-469B-82C5-E5C60FCC2F06</gtr:id><gtr:impact>~100 students attend this lecture which is part of a module with the following aims:
To provide students with - an understanding of the methods used to identify gene mutations causing Mendelian diseases - an illustration of how the genetic analysis Mendelian disorders has contributed to the understanding of the biology of human disease - an appreciation of the impact of research on the diagnosis and management of Mendelian diseases.

Increased awareness of mitochondrial research amongst undergraduates in biological sciences; several students have opted to do research projects in my laboratory as a result of this lecture</gtr:impact><gtr:outcomeId>BAU345WuVsn</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL ION Clinical Neuroscience MSc</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0DD07B47-3DC6-490A-917A-EBA2BB8A90F5</gtr:id><gtr:impact>Lectures on the following modules:
Module 1: Cellular and Molecular Mechanisms of Disease 'Mitochondrial genetics'
&amp;amp;
Module Three: Peripheral Nerve, Muscle &amp;amp; Special Senses
'Metabolic disorders of childhood, affecting nerve and muscle'

Increased awareness of metabolic and mitochondrial disease in adult neurology trainees</gtr:impact><gtr:outcomeId>LFkvB5LW1RM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/ion/education/courses/mscneuroscience1/module3</gtr:url><gtr:year>2010,2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mitochondrial medicine: a clinical guideline</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>ADCC617A-315E-4D4A-834D-7199991D9783</gtr:id><gtr:impact>Broad and practical overview of many aspects of patient care for mitochondrial disease - aimed at patients and relatives, medical students and healthcare professionals.

Free booklet available globally</gtr:impact><gtr:outcomeId>sqTY86emgDh</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;ved=0CCgQFjAA&amp;url=http%3A%2F%2Fwww.orpha.net%2Factor%2FEuropaNews%2F2012%2Fdoc%2FMitochondrialSample.pdf&amp;ei=SLtSVMOkM4_naNXjgOAP&amp;usg=AFQjCNGkzDwC-ylc3ZJ75CVf3enDzVYE6w&amp;bvm=bv.78597519,d.d2s</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Climb newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0557EEB4-136E-462C-9634-96196E155049</gtr:id><gtr:impact>2009: 'Mitochondrial Diseases: Challenges and Prospects' Climb Update 4(1) April 2009

2013: Article 'Finding the genetic cause of mitochondrial disease: high throughput analysis of genes implicated in cytochrome c oxidase deficiency' Climb Update 5(6):16 March 2013

Positive feedback from patients</gtr:impact><gtr:outcomeId>38756633382</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.climb.org.uk</gtr:url><gtr:year>2009,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Southwest Metabolic study day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>56510A6D-1361-4B23-A59A-69EA5003F82F</gtr:id><gtr:impact>Lectured on mitochondrial epilepsy to doctors, biochemists, nurses and dietitians interested in metabolic medicine - included our research findings in this talk

Patients referred for further research studies</gtr:impact><gtr:outcomeId>aSLzaNbAq1h</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Leigh network</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1041EEF1-C233-4D8F-A39E-0CF8F938DE33</gtr:id><gtr:impact>I was invited to talk about Leigh syndrome and lead a question and answer session at the annual meeting of the Leigh network patient support group in Windsor, October 2013. 
The Leigh Network mission: supports families affected by Mito both online and at Mito Meetings. We learn from each others experiences and Drs' knowledge and raise awareness

Increased public awareness of Leigh syndrome;
patients asking to participate in clinical trials.</gtr:impact><gtr:outcomeId>o9gXzBrYx6f</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://leighnetwork.tumblr.com/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Neuropathology Society Winter School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>07A8B64D-91FD-4CB4-87A5-86E18E814593</gtr:id><gtr:impact>Invited to lecture at the British Neuropathology Society Winter School in two consecutive years, on the following topics:
Mitochondrial Pathology
Mitochondrial Disorders and Epilepsy

Positive feedback from participants; increased referral of patients to my clinics and my research project.</gtr:impact><gtr:outcomeId>54633e26768243.62356187</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Adult Inborn Errors of Metabolism training day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C8019142-7247-43F5-8630-15FA082258C5</gtr:id><gtr:impact>Lecture and workshop - problem-based learning

Increased awareness of mitochondrial diseases amongst adult physicians</gtr:impact><gtr:outcomeId>F2p1JzmJ3PX</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=3&amp;ved=0CDEQFjAC&amp;url=http%3A%2F%2Fimperialendo.co.uk%2Finborn%2520errors%2520June%252025%25202008.pdf&amp;ei=c7FSVP2uLYL0aLT2glg&amp;usg=AFQjCNGUbLEUJ4xZO9aOU74YzYHttyHFMg&amp;bvm=bv.78597519,d.d2s</gtr:url><gtr:year>2008,2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL ICH Paediatrics MSc</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B477CC63-D979-4545-B2F5-B214CFF1DDC8</gtr:id><gtr:impact>Annual lecture to Clinical Paediatrics MSc students; also examine MSc proposals and theses, MCQ and unseen written papers and sit on Exam Board.

Increased knowledge and interest in mitochondrial diseases amongst paediatric trainees and younger consultants; recruited trainees into paediatric metabolic medicine.</gtr:impact><gtr:outcomeId>S1xX1sCDcy8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/msc-paediatrics-and-child-health</gtr:url><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Orphan Academy Adult Metabolic Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2E85AADC-6405-463A-8E49-7E63E0F026FB</gtr:id><gtr:impact>Lecture and Q and A session with adult physicians interested in metabolic disease around the world.

Increased awareness of my research; increased referrals.</gtr:impact><gtr:outcomeId>kRQKknDX9V7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://orphan-europe-academy.cyim.com/orphan-europe-academy</gtr:url><gtr:year>2008,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Climb patient support group annual symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C58BCAE-A9E2-474B-8DA9-15A169A512D4</gtr:id><gtr:impact>Talk to patient support group about challenges to genetic diagnosis and treatment of mitochondrial disorders.

Positive feedback from patients</gtr:impact><gtr:outcomeId>B702DE4A54F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.climb.org.uk/</gtr:url><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mitochondrial patient day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9002C84-2049-415C-9F14-8E85B84606C0</gtr:id><gtr:impact>Hosted day for people (patients/relatives/carers/friends) affected by mitochondrial disease, with short lectures, formal and informal discussion, stands with poster boards manned by laboratory staff (from neuropathology, clinical chemistry and molecular genetics), and facilitated workshop.

Positive feedback from patients and their families; request for similar day to be held on annual basis, which we have responded to. 
Latest patient day (2012) consolidated collaboration with the Centre for Reproductive and Genetic Health, UCL, which will allow development of preimplantation genetic diagnostic therapies for families with mitochondrial diseases.</gtr:impact><gtr:outcomeId>0464EA55876</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.cnmd.ac.uk/our_services/patients/patient_2</gtr:url><gtr:year>2008,2009,2011,2012,2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Human Fertilisation and Embryology Authority</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B3F56293-B8FE-4A0C-905B-43815A0B0486</gtr:id><gtr:impact>Review of the effectiveness and safety of methods to avoid mitochondrial disease: scientific workshop of the Human Fertilisation and Embryology Authority

Parliament amended guidance on use of embryos in mitochondrial research studies examining pronuclear transfer</gtr:impact><gtr:outcomeId>ZdKkRhPNDov</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>St Bartholomew's Medical School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8B14CF57-F308-416E-9296-A623D62DCB99</gtr:id><gtr:impact>Small group lecture about mitochondrial diseases and mitochondrial genetics to medical students at St Bartholomew's Medical School in January 2013

Increased knowledge and interest in mitochondrial diseases amongst medical students</gtr:impact><gtr:outcomeId>SfPH555rUZ4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICH Nephrology study day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>381D4F1A-8C8D-4BDF-931A-2BC144F44A73</gtr:id><gtr:impact>Approximately 100 attendees from all over the UK; mixture of consultant

Increased awareness of mitochondrial disease amongst paediatricians and nephrologists</gtr:impact><gtr:outcomeId>K8n2dLB4Ajp</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL Biological Sciences MSc</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>039BE382-4639-49EC-AB59-039A1B36F734</gtr:id><gtr:impact>To provide students with - an understanding of the methods used to identify gene mutations causing Mendelian diseases - an illustration of how the genetic analysis Mendelian disorders has contributed to the understanding of the biology of human disease - an appreciation of the impact of research on the diagnosis and management of Mendelian diseases.

Increased awareness of mitochondrial research amongst postgraduates in biological sciences; several students have applied for PhD positions in my laboratory as a result of this lecture</gtr:impact><gtr:outcomeId>GQedv4eDrnp</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sheffield Children's Hospital Metabolic Disease Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>83DA31BD-E15C-4674-A215-7B197AB9E7E3</gtr:id><gtr:impact>After giving a keynote presentation 'Mitochondrial disease and epilepsy' at the Trent Metabolic Study Day, Sheffield, November 2010, I was invited to write an accompanying article for the Sheffield Children's Hospital Metabolic Disease Newsletter

Increased awareness of my research; increased referrals.

This article was so well received that I was subsequently invited by the Editor of the journal Developmental Medicine and Child Neurology to expand it as a formal review article in this journal.</gtr:impact><gtr:outcomeId>PZGmwyYnwaM</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;ved=0CCEQFjAA&amp;url=http%3A%2F%2Fwww.sheffieldchildrens.nhs.uk%2Fdownloads%2Fmetabolicbiochemistry%2FMetabolicNewsletterSpring2011.pdf&amp;ei=CrJSVPD-IsLbaO_UgZgN&amp;usg=AFQjCNFBpvl93nI8NA95ocLnO7KpL</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Finnish Metabolic Klub</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>462D2F03-E919-4FF9-B3F8-306BAEEFA74A</gtr:id><gtr:impact>Lectured on mitochondrial epilepsy to doctors, biochemists, nurses and dietitians interested in metabolic medicine in Finland - included our research findings in this talk

Research collaboration</gtr:impact><gtr:outcomeId>Gi6j3BV9t9Q</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=5&amp;ved=0CDoQFjAE&amp;url=http%3A%2F%2Fkopi.med.helsinki.fi%2Fuser%2Fuploadedfiles%2F%2F%24HAKEMUS262156%24Metabklubi2011.doc&amp;ei=PbBSVIz5I9DWavyMgrAP&amp;usg=AFQjCNEO9VNJIiypapw7G7W3llfQtDOMDA&amp;bvm=bv.78</gtr:url><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queen Square neuromuscular study days</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C72165B5-C302-486B-A6F0-F008920082EA</gtr:id><gtr:impact>2006-2011 - Lectures about diagnosis and management of mitochondrial diseases, including reference to my research into the identification of nuclear genes for mitochondrial diseases.
2014 - Lecture about riboflavin transporter disorders (Brown-Vialetto-Van Laere syndrome)

Positive feedback from participants (high scores on evaluation forms); increased referral of patients to my clinics and my research project.</gtr:impact><gtr:outcomeId>B33605F6D4E</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.ucl.ac.uk/ion/articles/courses/update</gtr:url><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lily Family Weekend</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6D71892B-5EC3-44C7-AB02-12A9765A726D</gtr:id><gtr:impact>I gave an invited lecture twice to two separate audiences of ~50 people:
'How Do Doctors Diagnose Mitochondrial Disease?'


Positive feedback from patients and their families</gtr:impact><gtr:outcomeId>54564b7651cb52.59995603</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:url>http://www.thelilyfoundation.org.uk/lily-family-weekend/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public events on mitochondria replacement - panel member</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D29B44A3-1317-419C-8F43-8BBC3CB062E3</gtr:id><gtr:impact>Approximately 50 members of the public attended the event, which generated a vigorous debate about the proposed new germline gene therapy techniques proposed to prevent future cases of severe mitochondrial DNA disease.
I gave a 5 minute presentation explaining the scientific background to the debate, facilitated break out discussion groups and responded to questions in a 'Question Time' style discussion panel.

Because the new techniques involve the donation of DNA from a third party and will make changes to an embryo which affect the maternal line, they raise a range of ethical and social dilemmas. Will a child who is born from a mother, a father and a mitochondria donor have their identity affected by being conceived in this way? Would this form of embryo manipulation lead to more trivial uses of the technology in future? Should society prevent from being developed a treatment which could help couples avoid passing on debilitating diseases to their children?

Based on the results of the outcomes of the Public consultation events, the HFEA will advise the Secretary of State about public perceptions of the new germline gene therapy techniques.</gtr:impact><gtr:outcomeId>JWL373BYxgb</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.hfea.gov.uk/9359.html</gtr:url><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Ataxia UK Research Grant</gtr:description><gtr:fundingOrg>Ataxia UK</gtr:fundingOrg><gtr:id>7A8E1E99-32D1-4A1E-8906-0CB0EBE54B03</gtr:id><gtr:outcomeId>F23D4443A4F0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>731996</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Medical Research Council Cohort Grant</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0800674</gtr:fundingRef><gtr:id>2A96E9BB-1EFF-4AE8-9020-BCC1692C0086</gtr:id><gtr:outcomeId>mTRjRjVLD4N</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>149989</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Muscular Dystrophy Campaign Project grant</gtr:description><gtr:end>2015-01-02</gtr:end><gtr:fundingOrg>Muscular Dystrophy UK</gtr:fundingOrg><gtr:id>B4AC2587-D6A4-4FF5-8EB0-58B28BCB4382</gtr:id><gtr:outcomeId>Ue86ZxTgeT30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>42605</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Institute of Child Health</gtr:department><gtr:description>GOS/ICH Science Development Initiative</gtr:description><gtr:fundingOrg>University College London</gtr:fundingOrg><gtr:id>967159AC-B131-4174-BFF5-524C14757405</gtr:id><gtr:outcomeId>ZiR2ooQbxcA</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>271064</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Great Ormond Street Hospital Children's Charity - Neuroscience project grant</gtr:description><gtr:fundingOrg>Great Ormond Street Hospital Children's Charity (GOSHCC)</gtr:fundingOrg><gtr:id>C4A9F44A-84B2-45D4-93C9-34F4B901AE77</gtr:id><gtr:outcomeId>NYqK4k3CfgE0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Child Health Research Appeal Trust PhD studentship</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Child Health Research Appeal Trust (CHRAT)</gtr:fundingOrg><gtr:id>C4C91698-A092-4D77-BA91-F1552AF2A547</gtr:id><gtr:outcomeId>P4EbKijHsNU0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>32000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCLH CDRC Fast track project grant scheme/UCLH CDRC</gtr:description><gtr:fundingOrg>University College London Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>A7B05364-8149-40EF-BE27-FA51CCAAF62B</gtr:id><gtr:outcomeId>EdK4UvJhJoL0</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>232545</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Tranining Fellowship</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>88F2AE49-46A2-4F24-93A9-01FA9EE790DC</gtr:id><gtr:outcomeId>ea3XzHNCyUP</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CLDF Small Project Grant</gtr:description><gtr:fundingOrg>Children's Liver Disease Foundation (CLDF)</gtr:fundingOrg><gtr:id>46CB655A-74B4-4479-BAF3-E1ECB06934E4</gtr:id><gtr:outcomeId>WeqKViD3fq40</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>109252</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Vitaflo PhD Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Vitaflo International</gtr:fundingOrg><gtr:id>56C549F6-18F1-4FDB-B60B-C9E010084448</gtr:id><gtr:outcomeId>Ao5F4v29fec0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>238870</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Department of Health/Higher Education Council for England Best Research for Best Health Senior Clinical Lectureship</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Department of Health (DH)</gtr:fundingOrg><gtr:id>59E4AA06-3C75-4A48-9CCE-218A50B6D709</gtr:id><gtr:outcomeId>GSreqQ8tQRm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>272787</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Great Ormond Street Hospital Children's Charity</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Great Ormond Street Hospital Children's Charity (GOSHCC)</gtr:fundingOrg><gtr:fundingRef>V1220</gtr:fundingRef><gtr:id>C0A67DE2-2360-4979-95F6-2DCF137D622F</gtr:id><gtr:outcomeId>sgpPFUrZnBK</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Climb Project Grant</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Children Living with Inherited Metabolic Diseases (Climb)</gtr:fundingOrg><gtr:id>60911B6A-BA73-4362-973E-D43F2AB85CF2</gtr:id><gtr:outcomeId>Q6DGWYzhcQU0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Human Fertilisation and Embryology Authority</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D9E22FA-5662-44EA-B2E1-4C4A8AB73367</gtr:id><gtr:impact>Review of the effectiveness and safety of methods to avoid mitochondrial disease: scientific workshop of the Human Fertilisation and Embryology Authority</gtr:impact><gtr:outcomeId>VTQpDqhNdKg</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;ved=0CCoQFjAB&amp;url=http%3A%2F%2Fwww.hfea.gov.uk%2Fdocs%2F2011-04-18_Mitochondria_review_-_final_report.PDF&amp;ei=sSNVVNDpKYTB7AaC3IDYDA&amp;usg=AFQjCNGThW3khtY60tuEzinGZDjwapnMYQ&amp;bvm=bv.78677474,d.ZGU</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Public consultation on mitochondria replacement therapies</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8A61B610-3E5D-4856-9E69-A49B2B8260D5</gtr:id><gtr:impact>Information gathered during this national public consultation will be used to inform the Secretary of State for Health about the social and ethical impact of making new germline gene therapy techniques available to patients.</gtr:impact><gtr:outcomeId>sYhKijAJNrv</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type><gtr:url>http://www.google.co.uk/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;ved=0CCoQFjAB&amp;url=http%3A%2F%2Fwww.hfea.gov.uk%2Fdocs%2FMitochondria_replacement_consultation_-_advice_for_Government.pdf&amp;ei=gSRVVLfcJMyu7Aa7toCwCw&amp;usg=AFQjCNEV_QJGeg9JdylfOy-1HpNpKVdN7A&amp;bvm=bv.78677474,d.ZGU</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Identification of patients with mitochondrial disease who have a genetic condition responsive to supplementation with a vitamin or cofractor, namely:
-riboflavin transporter defects
-disorders of coenzyme Q10 biosynthesis
-cerebral folate deficiency (folate recptor defects)</gtr:description><gtr:id>4298FC21-FADB-490A-AB5F-F4A67BC0A06D</gtr:id><gtr:impact>Clinical improvement in patients who previously had a rapidly progressive course.
Some results have already been published; other manuscripts are currently in preparation.</gtr:impact><gtr:outcomeId>ZSLz442RuYr</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Vitamins and cofactors</gtr:title><gtr:type>Management of Diseases and Conditions</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>We are working with colleagues in genetics and reproductive medicine to provide prenatal and preimplantation genetic diagnosies for families affected with inherited mitochondrial disease.</gtr:description><gtr:id>64F4DB90-9183-4AE6-80B3-5962087D419D</gtr:id><gtr:impact>Several families have already received prenatal diagnosis, and several other families have been referred for preimplantation genetic diagnosis.</gtr:impact><gtr:outcomeId>JQCDA2k5n3Y</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>PND and PGD for mito disease</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Through NCG funding we are able to offer mitochondrial disease genetic testing (of both mitochondrial DNA and selected nuclear genes) from 3 UK centres (London, Newcastle and Oxford) of tests that were previously available only on a research basis. This means that many more patients are being offered tests (nationally funded so PCTs do not have to authorise funding) and receiving genetic diagnoses than in the past. The tests offered are continually being refined, to offer an optimal and equitable diagnostic service for patients.</gtr:description><gtr:id>C2A81EAD-4002-47C6-9F68-D442E3BBBF65</gtr:id><gtr:impact>Increased access to genetic testing and greatly improved diagnostic rates; for example the diagnostic rate has increased 5-fold (from 5 to 25%) for paediatric patients with mitochondrial disease.</gtr:impact><gtr:outcomeId>KXpT3ERf5bx</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Mitochondrial genetic testing</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Collection of cell lines from patients with mitochondrial diseases in whom we have identified specific genetic defects in mitochondrial or nuclear genes.</gtr:description><gtr:id>CDB6175E-3C4F-475A-BFBE-85F1819BF53A</gtr:id><gtr:impact>Research publications; material available for further research.</gtr:impact><gtr:outcomeId>FF83D216C93</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mitochondrial disease samples</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Demonstrated that FOXRED1 is a novel molecular chaperone needed for respiratory chain complex I assembly and/or function.</gtr:description><gtr:id>B21BC346-BB0F-471A-B85B-5EB11342C35D</gtr:id><gtr:impact>Publication in Human Molecular Genetics 2010</gtr:impact><gtr:outcomeId>TXBHrVZgSQd</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>complex I assembly</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Identified new gene COQ9 and demonstrated that it is involved in the human coenzyme Q10 biosynthetic pathway.</gtr:description><gtr:id>95DB59F9-EBB6-4AB2-B64F-1B7FC3A29AD9</gtr:id><gtr:impact>Publication in American Journal of Human Genetics 2009</gtr:impact><gtr:outcomeId>3677F395C95</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>coenzyme Q10 biosynthesis pathway</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Systematic review published as freely accessible article in the Journal of Medical Genetics (Fassone &amp;amp; Rahman 2012): systematic review of all published cases of nuclear-encoded complex I deficiency, including 117 cases with nuclear subunit mutations and 55 with assembly factor mutations, highlighting clinical, radiological and biochemical clues that may expedite genetic diagnosis.</gtr:description><gtr:id>E1FDC98C-1A8F-40CC-A2BA-2E87984B9641</gtr:id><gtr:impact>Genotype:phenotype correlation of complex I deficiency has led to improved diagnosis of patients: increased diagnostic rate and shorter time to diagnosis.</gtr:impact><gtr:outcomeId>QQKjFx3xrKp</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>complex I deficiency systematic review</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>24505D86-4764-4C18-A368-51ED8AD05333</gtr:id><gtr:title>POLG mutations and age at menopause.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5101faba6ba5604e10a697752dfd44ee"><gtr:id>5101faba6ba5604e10a697752dfd44ee</gtr:id><gtr:otherNames>Duncan AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>pm_13312_22_22552686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36C5C976-B79E-4C6D-B589-069ABFCD8DC7</gtr:id><gtr:title>Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e5ec211da0dca15b5656a9a543849cd"><gtr:id>5e5ec211da0dca15b5656a9a543849cd</gtr:id><gtr:otherNames>Rahman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>EA11734F260</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3253AC2-7AA2-4522-AEE1-4792439F7525</gtr:id><gtr:title>Complex I deficiency: clinical features, biochemistry and molecular genetics.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76f53b2e2804b93b99f1e55f2ec9630e"><gtr:id>76f53b2e2804b93b99f1e55f2ec9630e</gtr:id><gtr:otherNames>Fassone E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_13312_22_22972949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC8F6CB2-8DF1-4529-8D2C-432E2D7CC176</gtr:id><gtr:title>Analysis of mutant DNA polymerase gamma in patients with mitochondrial DNA depletion.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0f279786d09f909b2444464d0ac92f0"><gtr:id>d0f279786d09f909b2444464d0ac92f0</gtr:id><gtr:otherNames>Taanman JW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>98CF75538D7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0037949-DA84-41AC-BBEE-BE313EDAE9ED</gtr:id><gtr:title>176th ENMC International Workshop: diagnosis and treatment of coenzyme Q10 deficiency.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e5ec211da0dca15b5656a9a543849cd"><gtr:id>5e5ec211da0dca15b5656a9a543849cd</gtr:id><gtr:otherNames>Rahman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_13312_22_21723727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B2248E0-DD23-4823-B98F-FA4EB5C3346C</gtr:id><gtr:title>Kearns-Sayre syndrome caused by defective R1/p53R2 assembly.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_13312_22_21378381</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D0DFEE6-7263-4629-A714-0EA855B19CBF</gtr:id><gtr:title>FOXRED1, encoding an FAD-dependent oxidoreductase complex-I-specific molecular chaperone, is mutated in infantile-onset mitochondrial encephalopathy.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76f53b2e2804b93b99f1e55f2ec9630e"><gtr:id>76f53b2e2804b93b99f1e55f2ec9630e</gtr:id><gtr:otherNames>Fassone E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>YwnzBiGFCbt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE7DB8D2-CA0B-4B3C-B17C-D0035DFB2AF2</gtr:id><gtr:title>Diagnosis of mitochondrial DNA depletion syndromes.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e5ec211da0dca15b5656a9a543849cd"><gtr:id>5e5ec211da0dca15b5656a9a543849cd</gtr:id><gtr:otherNames>Rahman S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>30BF4109C4B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E863718-9978-478F-9E3B-CF120A4381C2</gtr:id><gtr:title>Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features.</gtr:title><gtr:parentPublicationTitle>Epilepsia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7bfe48d797880290a918b7553884b57"><gtr:id>e7bfe48d797880290a918b7553884b57</gtr:id><gtr:otherNames>Wolf NI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0013-9580</gtr:issn><gtr:outcomeId>661D8DF69DE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>151F7695-4B52-4480-BE09-31E6F5E070CB</gtr:id><gtr:title>A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>581f41b94ee606.53902727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4697F2CB-221D-47AD-A352-567B10F84879</gtr:id><gtr:title>A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5101faba6ba5604e10a697752dfd44ee"><gtr:id>5101faba6ba5604e10a697752dfd44ee</gtr:id><gtr:otherNames>Duncan AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>3136CBEA9B5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFB95EBB-569D-4DF7-89E3-68CFEC551DB2</gtr:id><gtr:title>Distal myopathy with cachexia: an unrecognised phenotype caused by dominantly-inherited mitochondrial polymerase ? mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_13312_22_22933815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F7D28A3-71A0-482C-8781-F681FC9EFE78</gtr:id><gtr:title>The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f950fd99d3923d0e32eb2c63f89184e9"><gtr:id>f950fd99d3923d0e32eb2c63f89184e9</gtr:id><gtr:otherNames>Fratter C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_13312_22_20479361</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50E0E8F9-85CF-4C33-ADFA-3F30042B98D2</gtr:id><gtr:title>Reactive oxygen species, oxidative stress, and cell death correlate with level of CoQ10 deficiency.</gtr:title><gtr:parentPublicationTitle>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b51162b9d823946b9c45133eccfe474"><gtr:id>1b51162b9d823946b9c45133eccfe474</gtr:id><gtr:otherNames>Quinzii CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0892-6638</gtr:issn><gtr:outcomeId>S3Wp8ndCg5F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4EF082E-DE38-442B-B245-F7767B78CA47</gtr:id><gtr:title>Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2.</gtr:title><gtr:parentPublicationTitle>Journal of inherited metabolic disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81004542f5536cf7ea20c548b192b8e3"><gtr:id>81004542f5536cf7ea20c548b192b8e3</gtr:id><gtr:otherNames>Glamuzina E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0141-8955</gtr:issn><gtr:outcomeId>pm_13312_22_22086604</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AFFB663-33AD-4812-912B-F8E7F645A743</gtr:id><gtr:title>Plasma thiol status is altered in children with mitochondrial diseases.</gtr:title><gtr:parentPublicationTitle>Scandinavian journal of clinical and laboratory investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b2b4e7b39d9b366411a6b5b085e5fbd"><gtr:id>6b2b4e7b39d9b366411a6b5b085e5fbd</gtr:id><gtr:otherNames>Salmi H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0036-5513</gtr:issn><gtr:outcomeId>pm_13312_22_22208644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>636CBB1A-C0F2-4EC1-9E2D-506BAB422F7A</gtr:id><gtr:title>Mutations in the mitochondrial complex I assembly factor NDUFAF1 cause fatal infantile hypertrophic cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76f53b2e2804b93b99f1e55f2ec9630e"><gtr:id>76f53b2e2804b93b99f1e55f2ec9630e</gtr:id><gtr:otherNames>Fassone E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>pm_13312_22_21931170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EAF9B02-2184-4E2C-BFDE-F601AD77DEF5</gtr:id><gtr:title>Treatment of CoQ(10) deficient fibroblasts with ubiquinone, CoQ analogs, and vitamin C: time- and compound-dependent effects.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb9d407effbbef85920759e27ad7e4e7"><gtr:id>eb9d407effbbef85920759e27ad7e4e7</gtr:id><gtr:otherNames>L?pez LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>iXSsceNU6jX</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0200335</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>